Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008059

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008059

U.S. Post-Surgical Scar Treatment Market, By Product Type, By Channel, By Scar Type, By Surgery Type, By End User

PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

U.S. Post-Surgical Scar Treatment Market is estimated to be valued at USD 3,927.9 Mn in 2026 and is expected to reach USD 7,686.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3,927.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.10% 2033 Value Projection: USD 7,686.0 Mn

Any burn, injury, or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depend on multiple factors such as the depth and size of the wound or the cut. It also depend upon the location of the wound, age, sex, and genes. There are various types of scars such as keloid scars, contracture scars, acne scars, and hypertrophic scars. Keloid scars are formed due to an over-aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include surgery, steroid injections, silicone sheets, and others. Hypertrophic scars are raised red scars and treatment of these scars include injection of steroids or silicone sheets.

Market Dynamics

Market players are engaged in inorganic growth activities such as acquisitions, and this is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, in April 2019, Merz, a company involved in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, an innovative U.S. consumer healthcare company, entered into an agreement to acquire the asset purchase agreement, according to which HRA Pharma will acquire the U.S. rights to the Mederma brand of Merz, which includes products across the scar care, stretch marks, and skincare categories.

Moreover, in October 2019, 3M, a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, completed the acquisition of Acelity, Inc., a medical device company, to expand its surgical applications business, which include advanced wound care and specialty surgical applications marketed under the KCI brand (PROMOGRAN) in the developed economies such as the U.S.

Key features of the study

  • This report provides an in-depth analysis of the U.S. post-surgical scar treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the U.S. post-surgical scar treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Molnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The U.S. post-surgical scar treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. post-surgical scar treatment market

Market Segmentation

  • By Product Type
    • Silicone sheets & Patches
    • Surgical tapes
    • Strips
    • Gels & Creams
    • Others
  • By Channel
    • OTC
    • Rx
  • By Scar Type
    • Atrophic Scars
    • Hypertrophic Scars
    • Keloid Scars
    • Contracture Scars
  • By Surgery Type
    • Caesarean Section
    • Joint Replacement
    • Appendectomy
    • Heart Surgery
    • Breast surgery
    • Others
  • By End User
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
  • Key Players
    • Smith & Nephew Plc.
    • 3M
    • Cardinal Health
    • Merz Pharma
    • Biodermis
    • Scar Heal, Inc.
    • Molnlycke Health Care AB
    • Implantech
    • Covalon Technologies Ltd.
    • Bio Med Sciences
    • Polymer Science, Inc.
    • Neodyne Biosciences, Inc.
Product Code: CMI4955

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Channel
    • Market Snippet, By Scar Type
    • Market Snippet, By Surgery Type
    • Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Industry Trends
  • Regulatory Scenario
  • Acquisitions, Partnerships & Agreements
  • Brand Analysis
  • Pricing Analysis
  • Epidemiology
  • Porter's Analysis
  • Number of Surgeries
  • Value Chain Analysis
  • Supply Chain Analysis
  • Distribution Landscape

4. U.S. Post-Surgical Scar Treatment Market, By Product Type, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Silicone sheets & Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Surgical tapes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Strips
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Gels & Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. U.S. Post-Surgical Scar Treatment Market, By Channel, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • OTC
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Rx
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. U.S. Post-Surgical Scar Treatment Market, By Scar Type, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Atrophic Scars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Hypertrophic Scars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Keloid Scars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Contracture Scars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. U.S. Post-Surgical Scar Treatment Market, By Surgery Type, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Caesarean Section
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Joint Replacement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Appendectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Heart Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Breast surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. U.S. Post-Surgical Scar Treatment Market, By End User, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

9. Competitive Landscape

  • Company Profiles
    • Smith & Nephew Plc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • 3M
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Cardinal Health Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Merz Pharma
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Biodermis
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Scar Heal, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Molnlycke Health Care AB
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Implantech
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Covalon Technologies Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Bio Med Sciences
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Polymer Science, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Neodyne Biosciences, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies

10. Section

  • Research Methodology
  • About us
  • Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!